Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation
- PMID: 6189942
- PMCID: PMC2186997
- DOI: 10.1084/jem.157.5.1618
Inhibition of antigen-specific T lymphocyte activation by structurally related Ir gene-controlled polymers. Evidence of specific competition for accessory cell antigen presentation
Abstract
The interaction of nominal Ag with major histocompatibility complex (MHC)-restricted T cells and accessory cells was studied by analyzing the effect of structurally related antigens on the response of antigen-specific MHC-restricted T cell hybridomas. The copolymer L-glutamic acid50-L-tyrosine50 (GT) completely inhibits the response of L-glutamic acid60-L-alanine40-L-tyrosine10 (GAT)-specific, I-Ad-restricted T cell hybridomas to GAT plus accessory cells. This inhibition is specific, as hybridomas of other specificities are not inhibited under identical conditions, and is unique to the GT antigen, as other similar copolymers are not inhibitory. The inhibitory effect is reversible by adding increasing amounts of GAT. Antigen-pulsing experiments localized the inhibition to the level of antigen-presenting cell (APC). GT-prepulsed APC are not inhibitory in cell-mixing experiments and can present other antigens. GT only inhibits the nominal antigen-directed component of a GAT-specific, autoreactive hybrid's response. Together these findings suggest that GT causes inhibition by competing for GAT association at the accessory cell. GT interferes with GAT presentation by an I-Adxb F1 APC to a BALB/c, I-Ad-restricted, but not B10, I-Ab-restricted, T cell hybridoma, and GT inhibits presentation by GAT-prepulsed APC. The implications of these findings for MHC-restricted presentation of antigen are discussed.
Similar articles
-
Selective modification of a private I-A allo-stimulating determinant(s) upon association of antigen with an antigen-presenting cell.J Exp Med. 1984 Apr 1;159(4):1238-52. doi: 10.1084/jem.159.4.1238. J Exp Med. 1984. PMID: 6200566 Free PMC article.
-
Antigen-specific suppressor T cell interactions. I. Induction of an MHC-restricted suppressor factor specific for L-glutamic acid50-L-tyrosine50.J Immunol. 1982 Jun;128(6):2447-52. J Immunol. 1982. PMID: 6176635
-
Antigen-specific suppression in genetic responder mice to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). Characterization of conventional and hybridoma-derived factors produced by suppressor T cells from mice injected as neonates with syngeneic GAT macrophages.J Exp Med. 1982 Dec 1;156(6):1691-710. doi: 10.1084/jem.156.6.1691. J Exp Med. 1982. PMID: 6184435 Free PMC article.
-
MHC-restricted T cell activation: analysis with T cell hybridomas.Immunol Rev. 1983;76:29-57. doi: 10.1111/j.1600-065x.1983.tb01096.x. Immunol Rev. 1983. PMID: 6363276 Review. No abstract available.
-
Processing requirements for the recognition of insulin fragments by murine T cells.Immunol Rev. 1988 Dec;106:59-75. doi: 10.1111/j.1600-065x.1988.tb00773.x. Immunol Rev. 1988. PMID: 2473028 Review.
Cited by
-
Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity.Cancer Immunol Immunother. 2004 Apr;53(4):315-22. doi: 10.1007/s00262-003-0448-x. Epub 2003 Dec 18. Cancer Immunol Immunother. 2004. PMID: 14685778 Free PMC article.
-
Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors.J Exp Med. 1984 Oct 1;160(4):1102-13. doi: 10.1084/jem.160.4.1102. J Exp Med. 1984. PMID: 6207262 Free PMC article.
-
Gene encoding T-cell-activating protein TAP maps to the Ly-6 locus.Proc Natl Acad Sci U S A. 1986 May;83(9):2954-8. doi: 10.1073/pnas.83.9.2954. Proc Natl Acad Sci U S A. 1986. PMID: 3010324 Free PMC article.
-
Selective modification of a private I-A allo-stimulating determinant(s) upon association of antigen with an antigen-presenting cell.J Exp Med. 1984 Apr 1;159(4):1238-52. doi: 10.1084/jem.159.4.1238. J Exp Med. 1984. PMID: 6200566 Free PMC article.
-
A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease.Springer Semin Immunopathol. 1992;14(1):95-101. doi: 10.1007/BF00197134. Springer Semin Immunopathol. 1992. PMID: 1440200 Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous